Theranos Inc. Elizabeth Holmes, founder of Elizabeth Homes, arrives in federal court on Wednesday, October 6, 2021 in San Jose, California.
David Paul Morris | Bloomberg | Getty Images
San Jose, Calif. — As Theranos’ problems escalated in 2014, blood-testing startups hired a dermatologist who wasn’t accredited by the lab’s science or pathology boards to head the lab.
Sunil Dhawan was temporarily played by the company’s chairman, Ramesh “Sunny” Balwani, according to court testimony on Thursday in a criminal trial by Theranos founder Elizabeth Holmes.
Davan was a Dermatologist in Balwani for a long time. He was called as a witness by a prosecutor who was trying to prove that Holmes had taken bills worth millions of dollars from investors, intentionally misleading patients and doctors about the company’s blood testing technology. Facing a 12-count count of wire fraud and plots, Holmes pleaded not guilty.
Davan testified that Barwani, who was in a romantic relationship with Holmes at the time, said, “The promise of time is negligible.” In an email in November 2014, Balwani also said, “This will primarily be an on-call consulting role,” said Davan, who met federal and state requirements to become laboratory director. ..
In a San Jose court, US Federal Attorney Jeff Schenk asked Dawn, “Did he explain to you what Theranos did?”
In response, Dawan said he had searched Google to learn about Theranos technology, adding that he “had a short chat about it.”
Davan testified that he only went to the lab twice between November 2014 and the summer of 2015, working a total of 5-10 hours. He told the jury that he had never met any staff, doctor or patient.
Davan was hired to replace Adam Rosendorff, who resigned in 2014, amid growing discontent over blood test inaccuracies and false results. Unlike Dawn, Rosendorff was a board-certified pathologist who spent every day in the lab.
Schenk continued, “Did you never talk to the Theranos employee working in the lab?”
“I don’t remember the conversation that happened during that period,” Davan said.
Davan said he did not meet Holmes until September 2015. He told the jury that he became more involved in the company that month as regulators planned to audit the institution.
During an interrogation, defense attorney Lance Wade, representing Holmes, asked Davan about Balwani’s importance in the company.
“Do you understand that he was one of the top two executives of the company?” Wade asked.
“My impression was that he was a top executive,” Davan said.
“He was running the institute from an operational standpoint, wasn’t he?” Wade asked.
“I can’t comment on this because he wasn’t told he ran the lab, but I thought he was,” Davan replied.
Balwani was charged with the same crime as Holmes. He too has been acquitted and will be tried separately next year. Daavan’s testimony continues on Friday as well.
Theranos Inc. Sunny Balwani, the company’s former president and chief operating officer, will leave federal court on October 2, 2019 in San Jose, California.
Michael Short | Bloomberg | Getty Images
Earlier on Thursday, Nimesh Javeli, a former senior executive at Walgreens, ran for office.
Jhaveri said Walgreens’ goal in partnership with Theranos was to enable customers to obtain lab results with just a few drops of blood. It is “extraordinary” to provide a more efficient and less painful procedure than traditional laboratories, Zaveli said.
“It was changing the lab environment,” Jhaveri said. “It was a real magic to need less blood. It was so interesting to us at Walgreens.”
Walgreens has invested $140 million in a failing company. Clinics with blood-testing technology are deployed at 40 drugstores in Arizona and one in California. In August 2014, a year after the partnership, Walgreens lowered its deployment target of 500 Theranos Wellness Centers to 200.
“Cost was a deterrent, training team members was a deterrent, and hiring a phlebotomist was a deterrent,” Jhaveri said. “The whole operating model was not complete, so we decided to scale it down.”
Jhaveri told Balwani that if he plans to expand, he needs to put in place a detailed plan to improve the patient experience. Under cross-examination, Jabeli told the jury that he had minimal contact with Holmes and had only met him a few times.
Walgreens said it was “a step back” when John Carrero, a former Wall Street Journal reporter, first broke the story of Theranos misleading customers and investors about test accuracy. Rice field. In 2016, Walgreens began unplugging Theranos service at its drugstores.
Look: Former employee and patient testify at Elizabeth Holmes trial
Theranos appointed Sunny Balwani’s dermatologist as laboratory director in 2014.
Source Link Theranos appointed Sunny Balwani’s dermatologist as laboratory director in 2014.